Home » Research » Liv.52 DS (tablet,syrup)

Total no. of papers:7 - Clinical Papers:7, Experimental Papers:0
(Research papers based on Indications)

Management of Non-Alcoholic Steatohepatitis (NASH)

  1. Evaluation of safety and efficacy of a Polyherbal formulation Liv.52 DS in the Management of Non-Alcoholic Steatohepatitis (NASH): An open clinical study.
    Santanu Ghosh1*, D P Singh2, K.D.Mandal3 and Suresh Kumar4.
    1Jawaharlal Nehru Medical College (JLN MCH), Bhagalpur, Bihar, India
    2TB & Chest Medicine, JLN MCH, Bhagalpur, Bihar, India
    3JLNMCH, Bhagalpur, Bihar, India
    4Department of Radiology, JLNMCH, Bhagalpur, Bihar, India
    Int.J.Curr.Res.Aca.Rev. 2014.2(9): 305-316

  2. Evaluation of Liv.52 DS and Ursodeoxycholic Acid in Nonalcoholic Steatohepatitis: A Comparative, Prospective, Randomized, Open Multicenter Trial
    Maity SG, Patki PS
    The Institute of Post Graduate Medical Education & Research (IPGME & R) and Seth Sukhlal Karnani Memorial (SSKM) Hospital, Kolkata, West Bengal, India.
    Probe. Vol I, No. 2, Jan-Mar 2011

In the prevention and treatment of viral hepatitis

  1. Evaluation of efficacy and safety of Liv.52 DS tablets in acute viral hepatitis: A prospective, double-blind, randomized, placebo-controlled, phase III clinical trial
    Dr. Rajiv Baijal, M.D., D.N.B.1, Dr. Nikhil Patel, M.D.,2 and Dr. S. A. Kolhapure, M.D.3* 1Gastroenterologist, 2Research Associates, Department of Gastroenterology, Jagjivanram Western Railway Hospital, Mumbai Central, Mumbai, India, 3Senior Medical Advisor, R&D Center, The Himalaya Drug Company, Bengaluru, India, Medicine Update 2004; 12(5), 41-53.

  2. Evaluation of safety and efficacy of a Polyherbal formulation Liv.52 DS in the Management of Non-Alcoholic Steatohepatitis (NASH): An open clinical study
    Santanu Ghosh1*, D P Singh2, K.D.Mandal3 and Suresh Kumar4
    1Jawaharlal Nehru Medical College (JLN MCH), Bhagalpur, Bihar, India.
    2TB & Chest Medicine, JLN MCH, Bhagalpur, Bihar, India.
    3JLNMCH, Bhagalpur, Bihar, India.
    4Department of Radiology, JLNMCH, Bhagalpur, Bihar, India.
    International Journal of Current Research and Academic Review, Volume 2 Number 9 (September-2014)

As an adjuvant with hepatotoxic drugs like anti-tubercular drugs, statins, chemotherapeutic agents, and antiretrovirals

  1. Liv.52 DS tablets: Evaluation of Liv.52 DS tablet as a hepatoprotective agent in prophylaxis with statin therapy
    Das, JKL, Associate professor, Department of Medicine, Patna Medical College, Patna, India, Prasad, S.R., Mitra S.K., R&D Center, The Himalaya Drug Company, Bengaluru, India. Medicine Update 2007; 15(7): 31-36

In the prevention and treatment of alcoholic liver disease

  1. Study of the efficacy and safety of Liv.52 DS tablets in alcoholic hepatitis: Clinical, biochemical and ultrasonographic evaluation.
    Arun Kumar Mahto, Professor and HOD, Chief Investigator, Sailal, M., Junior Resident, Assistant Investigator and Monitor, Department of Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India. Indian Medical Journal 2009; 103(5): 150-158.

  2. Liv.52 DS tablets: Evaluation of efficacy and safety in alcoholic liver cirrhosis
    Subhash Agal, Dept. of Gastroenterology, Jagagivanram Western Railway Hospital, Mumbai, and Dr. Prasad, S.R., Mitra S.K., R&D Center, The Himalaya Drug Company, Bengaluru, India. Medicine Update 2007; 15(6): 25-32